SAB Biotherapeutics, Inc. (SABS)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous Close | 4.0300 |
| Open | 4.1000 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 3.9400 - 4.1800 |
| 52 Week Range | 3.9400 - 10.5000 |
| Volume | |
| Avg. Volume | 13,331 |
| Market Cap | 36.348M |
| Beta (5Y Monthly) | 0.80 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
SAB Biotherapeutics Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
SAB Biotherapeutics ( NASDAQ:SABS ) Full Year 2023 Results Key Financial Results Net loss: US$42.2m (loss widened by...
- Simply Wall St.
Individual investors are SAB Biotherapeutics, Inc.'s (NASDAQ:SABS) biggest owners and were rewarded after market cap rose by US$535m last week
Key Insights SAB Biotherapeutics' significant individual investors ownership suggests that the key decisions are...
© 2024 Yahoo. All rights reserved.